COVID-19 Update - This is to inform you that the Government of India has announced a complete lockdown in India 22nd March 2020 to 3rd May 2020. As a result, our offices will now be closed till 3rd May 2020 and all our employees will be working from home. Office telephones will not be answered, and therefore you are requested to direct all your queries related to manuscript submission, review process, publication etc. at below mentioned details. editor@innovativepublication.com, rakesh.its@gmail.com, Mob. 8826373757, 8826859373, 9910947804


Print ISSN:-2394-2789

Online ISSN:-2394-2797

CODEN : IJPCN9

Current Issue

Year 2020

Volume: 7 , Issue: 1

Article Access statistics

Viewed: 369

Emailed: 0

PDF Downloaded: 169

International Journal of Pharmaceutical Chemistry and Analysis


A rare case report on guillain barre syndrome and rheumatoid arthritis


Full Text PDF Share on Facebook Share on Twitter


Case Report

Author Details : Shaik Bobby Parveen, Bhushanam Gayatri, Chandolu Suvarna Rani, Bandaru Praveena*, Konda Ravi Kumar

Volume : 6, Issue : 1, Year : 2019

Article Page : 24-26


Suggest article by email

Abstract

Guillain Barre syndrome (GBS) is an acute or subacute inflammatory demyelinating poly radiculoneuropathy. It is an acquired condition that is characterized by progressive, symmetrical, proximal, and distal tingling and weakness. We report a case of a 68 years old female who presented with complaints of quadraperisis, severe sensory motor axonal neuropathy, parasthesia, severe myalgiapoly arthralgia and mononeuritis multiplex and later diagnosed as a case of guillainbarre syndrome and rheumatoid arthritis.

Keywords: GBS, Rheumatoid arthris, Immunoglobulins, Corticosteroids, Acute or subacute inflammatory demyelinating polyradiculoneuropathy, Plasma pherisis.

Doi : 10.18231/j.ijpca.2019.005

How to cite : Parveen S B, Gayatri B, Rani C S, Praveena B, Kumar K R, A rare case report on guillain barre syndrome and rheumatoid arthritis. Int J Pharm Chem Anal 2019;6(1):24-26

Copyright © 2019 by author(s) and Int J Pharm Chem Anal. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC-BY-NC 4.0) (creativecommons.org)